Does RIFAXIMIN Cause Gait inability? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Gait inability have been filed in association with RIFAXIMIN (XIFAXAN). This represents 0.1% of all adverse event reports for RIFAXIMIN.
19
Reports of Gait inability with RIFAXIMIN
0.1%
of all RIFAXIMIN reports
4
Deaths
18
Hospitalizations
How Dangerous Is Gait inability From RIFAXIMIN?
Of the 19 reports, 4 (21.1%) resulted in death, 18 (94.7%) required hospitalization, and 1 (5.3%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIFAXIMIN. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does RIFAXIMIN Cause?
Death (3,687)
Hospitalisation (1,605)
Therapy interrupted (875)
Off label use (802)
Diarrhoea (709)
Ammonia increased (676)
Inability to afford medication (672)
Insurance issue (577)
Confusional state (530)
Hepatic cirrhosis (480)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which RIFAXIMIN Alternatives Have Lower Gait inability Risk?
RIFAXIMIN vs RILMENIDINE
RIFAXIMIN vs RILONACEPT
RIFAXIMIN vs RILPIVIRINE
RIFAXIMIN vs RILUZOLE
RIFAXIMIN vs RIMABOTULINUMTOXINB